EP2582468A1 — Inhaler
Assigned to Boehringer Ingelheim International GmbH · Expires 2013-04-24 · 13y expired
What this patent protects
An inhaler (1) is proposed having an insertable container (3) and a monitoring device (24) for counting uses of the inhaler. The monitoring device is arranged in a detachable housing part (18) or fitted onto a mouthpiece (13) of the inhaler. A supply air current is detected by me…
USPTO Abstract
An inhaler (1) is proposed having an insertable container (3) and a monitoring device (24) for counting uses of the inhaler. The monitoring device is arranged in a detachable housing part (18) or fitted onto a mouthpiece (13) of the inhaler. A supply air current is detected by means of a pressure sensor (29). A position sensor may further be provided.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.